These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6292799)

  • 21. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system.
    Pasternak GW; Gintzler AR; Houghten RA; Ling GS; Goodman RR; Spiegel K; Nishimura S; Johnson N; Recht LD
    Life Sci; 1983; 33 Suppl 1():167-73. PubMed ID: 6319856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone.
    Holaday JW; Pasternak GW; D'Amato RJ; Ruvio BA; Faden AI
    Eur J Pharmacol; 1983 May; 89(3-4):293-6. PubMed ID: 6307712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    Di Chiara G; Imperato A
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1067-80. PubMed ID: 2855239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cataleptic effects of opiates following intrathecal administration.
    Watkins LR; Frenk H; Miller J; Mayer DJ
    Brain Res; 1984 May; 299(1):43-9. PubMed ID: 6326964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI; Mayfield MA; McCann SM; Krulich L
    Life Sci; 1984 May; 34(19):1829-37. PubMed ID: 6330479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.
    Pfeiffer A; Pfeiffer DG; Feuerstein G; Faden AI; Kopin IJ
    Brain Res; 1984 Apr; 296(2):305-11. PubMed ID: 6322927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study.
    Brady LS; Herkenham M; Long JB; Rothman RB
    Brain Res; 1989 Jan; 477(1-2):382-6. PubMed ID: 2539233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereospecific interaction between alcohol and opiates mediated by the mu high-affinity binding receptor.
    Ng Cheong Ton JM; Amit Z
    Alcohol; 1985; 2(2):333-7. PubMed ID: 2990506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of morphine and naloxone upon the reactions of rats to a heat stressor.
    Westbrook RF; Greeley JD; Nabke CP; Swinbourne AL; Harvey A
    Q J Exp Psychol B; 1991 Aug; 43(3):323-46. PubMed ID: 1658853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mu-opiate binding and morphine antagonism by octapeptide analogs of somatostatin.
    Walker JM; Bowen WD; Atkins ST; Hemstreet MK; Coy DH
    Peptides; 1987; 8(5):869-75. PubMed ID: 2893361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats.
    Bolger GT; Skolnick P; Rice KC; Weissman BA
    FEBS Lett; 1988 Jul; 234(1):22-6. PubMed ID: 2839362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine analgesia is potentiated in adult rats prenatally exposed to ethanol.
    Nelson LR; Taylor AN; Lewis JW; Branch BJ; Liebeskind JC
    Brain Res; 1986 May; 372(2):234-40. PubMed ID: 3011208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S; Bykov V; Lessor RA; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1987 Oct; 142(1):73-81. PubMed ID: 2826178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.